Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy (Q33348438)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy (English)

1 reference

Europe PubMed Central

26 July 2017

0 references

diabetic nephropathy

1 reference

based on heuristic

inferred from title

author name string

Minoru Satoh

1

1 reference

Europe PubMed Central

26 July 2017

Sohachi Fujimoto

2

1 reference

Europe PubMed Central

26 July 2017

Sayaka Arakawa

3

1 reference

Europe PubMed Central

26 July 2017

Toyotaka Yada

4

1 reference

Europe PubMed Central

26 July 2017

Tamehachi Namikoshi

5

1 reference

Europe PubMed Central

26 July 2017

Yoshisuke Haruna

6

1 reference

Europe PubMed Central

26 July 2017

Hideyuki Horike

7

1 reference

Europe PubMed Central

26 July 2017

Tamaki Sasaki

8

1 reference

Europe PubMed Central

26 July 2017

Naoki Kashihara

9

1 reference

Europe PubMed Central

26 July 2017

language of work or name

0 references

publication date

2 July 2008

1 reference

Europe PubMed Central

26 July 2017

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

26 July 2017

23

1 reference

Europe PubMed Central

26 July 2017

12

1 reference

Europe PubMed Central

26 July 2017

3806-3813

1 reference

Europe PubMed Central

26 July 2017

Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639062

21 June 2018

Requirement of Rac1 in the development of cardiac hypertrophy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639062

21 June 2018

Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639062

21 June 2018

Microalbuminuria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639062

21 June 2018

NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639062

21 June 2018

The two faces of endothelial nitric oxide synthase in the pathophysiology of atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639062

21 June 2018

The mechanisms underlying altered vascular resistance of glomerular afferent and efferent arterioles in diabetic nephropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639062

21 June 2018

Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639062

21 June 2018

HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639062

21 June 2018

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639062

21 June 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639062

21 June 2018

Generation of superoxide by purified brain nitric oxide synthase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639062

21 June 2018

Effects of angiotensin type-1 receptor antagonism on small artery function in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN357

21 January 2018

Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN357

21 January 2018

Effects of NADPH oxidase inhibitor in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN357

21 January 2018

Nephron number and renal risk in hypertension and diabetes

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN357

21 January 2018

Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN357

21 January 2018

Candesartan Reduces Oxidative Stress and Inflammation in Patients with Essential Hypertension

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN357

21 January 2018

Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN357

21 January 2018

Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN357

21 January 2018

Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN357

21 January 2018

Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN357

21 January 2018

Olmesartan ameliorates progressive glomerular injury in subtotal nephrectomized rats through suppression of superoxide production

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN357

21 January 2018

Proteasome-dependent degradation of guanosine 5'-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639062

31 October 2018

Gene transfer of human guanosine 5'-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639062

31 October 2018

Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639062

31 October 2018

Protein Kinase C Phosphorylates and Activates GTP Cyclohydrolase I in Rat Renal Mesangial Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18596126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mouse models of diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18596126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decrease in tetrahydrobiopterin as a possible cause of nephropathy in type II diabetic rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/18596126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration

1 reference

https://pubmed.ncbi.nlm.nih.gov/18596126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/NDT/GFN357

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33348438&oldid=1588278822"